Navigation Links
Phenylketonuria in Medical News

Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan

... dihydrochloride) for the treatment of phenylketonuria (PKU). The patent for stable tablet formulation ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a ... )(sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck ...

BioMarin Receives 2009 Corporate Award for the Development of Kuvan

... toward improving the lives of people living with phenylketonuria (PKU). NORD honored BioMarin for the ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). PKU is a rare genetic disorder that can ... Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck ...

JCI online early table of contents: July 1, 2008

... Bringing stability to the protein defective in phenylketonuria phenylketonuria (PKU) is an inherited disease characterized by ... as potential therapeutic agents to treat phenylketonuria AUTHOR CONTACT: Aurora Martinez University ...

BioMarin Announces Second Quarter 2009 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $16.9 million for the second quarter of 2009, compared to $12.0 ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study

... (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). The company expects to initiate the Phase 2 clinical study in late ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director

... dedicated to supporting those affected by the genetic disorder phenylketonuria (PKU), today announced that it has selected Christine Brown to be its ... Violence Coordinating Council in Maryland. About PKU PKU, or phenylketonuria (pronounced fen-il-Key-to-New-ree-uh ) is a lifelong genetic disorder in ...

Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)

... Tablets, the first specific drug therapy approved for the treatment of phenylketonuria (PKU). Kuvan was approved by the U.S. Food and Drug Administration (FDA) ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono

... Darmstadt, Germany. Kuvan is an oral small molecule for the treatment of phenylketonuria (PKU) developed in partnership with Merck Serono. Based on published ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

Meta-Analysis of Blood Phe Levels and Clinical Outcomes in PKU Published

... meta-analysis of blood phenylalanine (Phe) levels and clinical outcomes in phenylketonuria (PKU) was published in the September/October 2007 issue of Molecular ... dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in ...

Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome

... developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...
Phenylketonuria in Medical Technology

BioMarin Announces FDA Approval for Kuvan

... Tablets, the first specific drug therapy approved for the treatment of phenylketonuria (PKU). Shipments to the distribution channel will commence tomorrow, and ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet

... with Kuvan results in significant reductions in blood Phe levels in some phenylketonuria (PKU) patients. Kuvan, an investigational oral small molecule for the ... dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in ...

BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome

... developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...

BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health

... Corporation. Investigational product candidates include Kuvan(TM) (sapropterin dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease ...
Phenylketonuria in Medical Definition

Pathology

... - Hypervitaminosis D v • d • e Metabolic pathology ( E70-90 , 270-279 ) Amino acid Aromatic ( phenylketonuria , Alkaptonuria , Ochronosis , Tyrosinemia , Albinism , Histidinemia ) - Branched chain ( Maple syrup urine disease , Propionic acidemia , ...
Phenylketonuria in Medical Dictionary

Phenylalanine

... make the protein s that form human tissue s. phenylketonuria ( PKU ) ... 6. D- phenylalanine derivatives ... people that have a rare genetic order called phenylketonuria , also known as PKU . - L-dopa (L-dihydroxy ... One of the best known examples of this is phenylketonuria ( PKU ). This is an genetic error in ...

Phenylketonuria

... phenylketonuria ( PKU ) is inherited as an autosomal recessive ... gene for the child to be affected). phenylketonuria is a type of birth defect a child inherits ... parents, who pass along the abnormal gene . phenylketonuria , maternal: See Maternal ...

Pku

... PKU : Short for phenylketonuria . See: phenylketonuria . Search All of MedicineNet For: search help Printer-Friendly Format ... More on Pku phenylketonuria - inherited metabolic disorder caused by the ...

Circumcision

... Bottle- Feeding , Breast-Feeding , Circumcision , Crying , Age 3 and Younger, Immunizations , Jaundice in Newborns (Hyperbilirubinemia), phenylketonuria ( PKU ), Rash , Age 11 and Younger, Scalp Problems, Shaken Baby Syndrome , ... Ciliary Body Cimetidine (H2 Receptor Antagonists) Cinfacrom ...

Drug

... Drug Administration (FDA) to be safe for use by almost all people. The exception is for those very rare people who are born with a condition called phenylketonuria ( PKU ). Allergic vasculitis is hypersensitivity to a drug or foreign agent that leads to inflammation and damage to blood vessels of the ...

Encephalitis

... nausea , vomiting , and nervous system problems. Several types of opportunistic infections can cause encephalitis . encephalitis untreated phenylketonuria The severity of the condition varies between individuals, ranging from the most severe (extremely unusual, repetitive, self- injurious, and ...

Fetus

... fetus has an increased risk for developing a congenital heart defect when the mother has one of the following medical conditions: 4 Diabetes phenylketonuria (back to top) ... If fetus mature, consider delivery for fetal indications. If immature, repeat BPP within 24 hours 6/10 abnormal AFV High ...

Galactose

... weeks of age. The most common newborn screening tests in the U.S. include those for hypothyroidism (underactivity of the thyroid gland ) , PKU ( phenylketonuria ), galactose mia , ... ...

Galactosemia

... defect, to what Garrod called an "inborn error of metabolism ." Today, newborns are routinely screened for certain enzyme defects such as PKU ( phenylketonuria ) and galactosemia , ... Other factors which can potentiate jaundice in the newborn include: sepsis , biliary atresia , Rh incompatibility, ...

Ketones

... including CBC and blood chemistry (chem-20) Urine analysis for ketones and severity of dehydration Pregnancy test s ... untreated phenylketonuria , a problem in the body's ability to handle certain chemicals named phenyl ketones lack of oxygen during birth encephalitis or other serious ...

More>>

Phenylketonuria in Biological News

UW-Madison study reveals new options for people with PKU

... MADISON For people with the genetic condition known as phenylketonuria (PKU), diet is a constant struggle. They can eat virtually no protein, and instead get their daily dose of this key macronutrient by drinking a ...

New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease

... Margie Fischer doesn't have to imagine it; that was normal life at her family's dinner table for years. Her daughter Maggie, now 20, suffers from phenylketonuria (PKU), a genetic disease that means her body can't tolerate anything more than a low-protein diet. PKU is described by scientists as an autosomal ...

Children's Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach

... IL, Children's Memorial Hospital of Chicago announced today that it has received a grant from BioMarin Pharmaceutical Inc. to support its Adult phenylketonuria (PKU) Outreach Education Project. The goal of the program is to conduct outreach to PKU patients who are no longer being treated at PKU clinics to ...

Nationwide Children's Hospital involved in expanded access program for treatment of PKU

... announced today its involvement in an expanded access program for sapropterin dihydrochloride, or sapropterin, an investigational treatment for phenylketonuria (PKU), a rare genetic metabolic disorder that, if left unmanaged in infants and children, can result in severe mental retardation. Currently, there ...

Birth defects: 8 million annually worldwide

... with genetic disorders; Establish newborn screening programs to identify babies born with devastating but treatable metabolic disorders such as phenylketonuria (PKU); Educate women and men of childbearing age about how they can work with health professionals to maximize the chances of having a healthy ...
Phenylketonuria in Biological Technology

Kuvan Receives Priority Review Status From Health Canada

... as an oral treatment for patients with phenylketonuria (PKU) from Health Canada. Priority review ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a ... (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck ...

BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan

... (sapropterin dihydrochloride) in the treatment of phenylketonuria (PKU). The company expects that the patent will ... due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a ... Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck ...

Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics

... Phenylalanine (Phe) tolerance in children with phenylketonuria (PKU) maintained on a Phe-restricted diet ... (sapropterin) in children with phenylketonuria (PKU) on a phenylalanine (Phe)-restricted diet ... treatment over 22 weeks in patients with phenylketonuria (PKU) (Randolph) -- 2231 -- Dose-related ...

BioMarin Announces First Quarter 2009 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $15.5 million for the first quarter of 2009, compared to $5.8 ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $15.1 million for the fourth quarter of 2008 and $46.7 million ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

BioMarin Announces Third Quarter 2008 Financial Results

... (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), was $13.8 million for the third quarter of 2008 and $31.6 million ... Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck ...

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU

... ingredient as Kuvan(R) in the U.S., for the treatment of patients with phenylketonuria (PKU). BioMarin will receive a milestone payment of $1.5 million for this ... hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet. ...

Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan

... Labour and Welfare for approval of its BH4 product for the treatment of phenylketonuria (PKU) in Japan. The application is for a label extension for its current ... dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in ...

BioMarin to Present at the Jefferies Healthcare Conference

... a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...

BioMarin to Present at the Goldman Sachs Healthcare Conference

... a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL ...
Phenylketonuria in Biological Definition

Enzyme

... 2,000 types present in our bodies can lead to severe or lethal illness. An example of a disease caused by an enzyme malfunction in humans is phenylketonuria (PKU). The enzyme phenylalanine hydroxylase , which usually converts the essential amino acid phenylalanine into tyrosine does not work, resulting ...

Guthrie test

... on blood samples taken from the heel of the baby, at or before 4 days of age. The test typically screens for the following diseases: phenylketonuria Hypothyroidism Cystic Fibrosis Galactosemia ...
Other Contents
(Date:7/26/2014)... July 26, 2014 The European security ... at $1290 million in 2014, and it is expected ... of 6.16%. The report incorporates the factors that influence ... of growth rates and projected total expenditure. The report ... global markets. Apart from the general overview of the ...
(Date:7/26/2014)... The North America Cyber Security report ... North America with analysis and forecast of revenue. This ... in 2014 to $33.24 billion by 2019, at a ... through the TOC of the North America Cyber Security ... analysis provided. It also provides a glimpse of the ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 The European Artificial ... in Europe with analysis and forecast of revenue. The artificial ... $3.5 billion in 2013 to around $5.4 billion by 2018, ... , Browse through the TOC of European artificial lift market ... also provides a glimpse of the segmentation in European Artificial ...
(Date:7/26/2014)... 2014 The European gas chromatography reagents report ... and forecast of revenue. The gas chromatography reagents market in ... is estimated to grow to around $445.5 million by 2018, ... , Browse through the TOC of the European gas chromatography ... provided. This report also provides a glimpse of the segmentation ...
(Date:7/26/2014)... 26, 2014 Recently, iFitDress.com, a popular ... women, has unveiled its new range of high quality ... on the brand new items; they are now provided ... , iFitDress.com is one of the leading suppliers in ... all the wholesale party dresses have flattering ...
Breaking Medicine News(10 mins):Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 4Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 5Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Cyber Security Market is Expected to Reach $33 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 5Health News:High Quality Wholesale Party Dresses Online at iFitDress.com 2
(Date:7/25/2014)... first broad-scale estimate of air pollution removal by trees ... trees are saving more than 850 human lives a ... , While trees, pollution removal equated to an average ... impacts of that improvement are substantial. Researchers valued the ... nearly $7 billion every year in a study published ...
(Date:7/25/2014)... of people lived on the land now called California, ... the availability of plants they used for food, fuel, ... to maintain desired habitat and natural resources. , Frank ... Southwest Station, will lead a field trip ... Ecological Society of America,s 99th Annual Meeting, in Sacramento, ...
(Date:7/25/2014)... image from the Terra satellite show the different areas that ... Eastern Russia. The burn scars show up as reddish-brown ... have broken across the remote parts of Eastern Russia in ... the MODIS instrument, it is still possible to see ... image features noted below show the devastating number of fires ...
Breaking Biology News(10 mins):First national study finds trees saving lives, reducing respiratory problems 2Fire ecology manipulation by California native cultures 2Fire ecology manipulation by California native cultures 3
Other TagsOther Tags